The epidemiology of amphetamine type stimulant-related admissions in Albany, Western Australia: Changes 10 years on

ObjectiveTo identify longitudinal changes in the number and demographics of amphetamine type stimulant (ATS)-related admissions to a rural hospital, in comparison with findings from 2008-2013 and national trends.MethodA retrospective quantitative epidemiological study of patients admitted to Albany Health Campus from 2018 to 2023 with an International Classification of Diseases-10 (ICD-10) code related to ATS. Age, gender, Indigenous status, and ATS-related ICD-10 code were compared over time, including repeat admissions. Substance used, ward, and comorbidities were observed.ResultsOne hundred and seventy-nine admissions with an ATS-related primary diagnosis were identified, and a further 549 admissions with an ATS-related additional diagnosis. The mean age was 34.1, 55.9% were female, and 46.9% were Aboriginal. Repeat admissions accounted for 53.6% of total events. The most common ATS-related diagnosis code was F15.1 (harmful use) followed by F15.5 (psychotic disorder). Most admissions involved methamphetamine use and were to the mental health unit. Fifty-three percent had at least one comorbidity.ConclusionBoth overall and repeat ATS-related admissions to Albany Health Campus have increased since the last decade. There is a growing proportion of female and older patients, and Aboriginal people are overrepresented. Many patients have comorbidities further complicating their hospitalisations.